2 min read Health Servier India introduces‘Ivosidenib’ (Tibsovo®),in India, First-in-classTargetedTherapy in Oncologyfor Rare IDH1-Mutated AML and Cholangiocarcinoma June 12, 2025 timesofgujarat 2025-Servier India, a subsidiary of the leading French pharmaceutical Servier Group, announced the launch...
